| Literature DB >> 30851675 |
Sungkean Kim1, Seon-Kyeong Jang2, Do-Won Kim3, Miseon Shim4, Yong-Wook Kim1, Chang-Hwan Im5, Seung-Hwan Lee6.
Abstract
BACKGROUND: Abnormalities in the 40-Hz auditory steady-state response (ASSR) of the gamma range have been reported in schizophrenia (SZ) and are regarded as important pathophysiological features. Many of the previous studies reported diminished gamma oscillations in SZ, although some studies reported increased spontaneous gamma oscillations. Furthermore, brain morphological correlates of the gamma band ASSR deficits have rarely examined. We investigated different measures of the 40-Hz ASSR and their association with brain volumes and psychological measures of SZ.Entities:
Keywords: 40-Hz ASSR; Gamma oscillation; STG volume; Schizophrenia; Voxel-based morphometry
Mesh:
Year: 2019 PMID: 30851675 PMCID: PMC6407311 DOI: 10.1016/j.nicl.2019.101732
Source DB: PubMed Journal: Neuroimage Clin ISSN: 2213-1582 Impact factor: 4.881
Demographic characteristics of patients with SZ and HCs.
| SZ (N = 33) | HC (N = 30) | ||
|---|---|---|---|
| Age (years) | 42.21 ± 10.99 | 43.33 ± 12.95 | 0.711 |
| Sex | |||
| Male | 16 (48.5) | 13 (43.3) | 0.682 |
| Female | 17 (51.5) | 17 (56.7) | |
| Premorbid IQ | 103.03 ± 9.86 | 107.85 ± 9.34 | 0.059 |
| Education (years) | 13.85 ± 2.06 | 13.87 ± 3.81 | 0.982 |
| Number of hospitalization | 2.82 ± 3.30 | ||
| Duration of illness (years) | 13.57 ± 8.90 | ||
| Onset age (years) | 27.83 ± 9.83 | ||
| Dosage of antipsychotics (chlorpromazine equivalent, mg) | 495.06 ± 558.53 | ||
| Positive and negative syndrome scale | |||
| Positive | 13.06 ± 6.57 | ||
| Negative | 16.45 ± 6.19 | ||
| General | 29.61 ± 8.30 | ||
| Total | 59.12 ± 18.93 | ||
| TMT-A (seconds) | 31.28 ± 13.35 | 28.38 ± 10.24 | 0.351 |
| TMT-B (seconds) | 107.47 ± 53.55 | 84.97 ± 50.40 | 0.108 |
| Verbal fluency | 15.91 ± 4.84 | 19.00 ± 5.82 | 0.027 |
| K-AVLT – delayed recall | 6.31 ± 3.65 | 9.89 ± 2.08 | < 0.001 |
| SFQ | 44.88 ± 11.96 | 40.14 ± 7.77 | 0.066 |
| SOFAS | 63.73 ± 13.59 |
HC, healthy control; IQ, intelligence quotient; K-AVLT, Korean Auditory Verbal Learning Test; SFQ, Social Functioning Questionnaire; SOFAS, Social and Occupational Functioning Assessment Scale; SZ, schizophrenia; TMT-A, Trail Making Test-A; TMT-B, Trail Making Test-B.
Fig. 1The grand average of time-frequency maps and time course of total power, evoked power, and inter-trial phase coherence at Cz in the 40-Hz frequency for patients with SZ and HCs. Bars in the time course indicate the standard error. HC, healthy control; SZ, schizophrenia.
Fig. 2The mean evoked power (0–500 ms) at Cz was significantly associated with right STG volume in HCs, while it was not significantly associated with right STG volume in patients with SZ. SZ: mean evoked power = − 1.602 * right STG volume – 0.002 * TIV – 0.002 * CPZ equivalent +0.036 * duration of illness +19.721 + error, HC: mean evoked power = 2.031 * right STG volume – 0.012 * TIV + 9.196 + error. CPZ, chlorpromazine; HC, healthy control; STG, superior temporal gyrus; SZ, schizophrenia; TIV, total intracranial volume.
Fig. 3Mean evoked power (0–500 ms) was significantly correlated with verbal fluency in patients with SZ, while it was not significantly associated with verbal fluency in HCs. SZ: verbal fluency = − 0.407 * mean evoked power – 0.001 * CPZ equivalent – 0.165 * duration of illness +21.204 + error, HC: verbal fluency = 0.333 * mean evoked power + 17.770 + error. CPZ, chlorpromazine; HC, healthy control; SZ, schizophrenia.